[1]
|
龚春竹, 程昕然, 鄢力, 李中会, 苟鹏, 唐芳, 苏娜, 冷洁, 汪柳絮, 杜思泓. 新生儿先天性肾上腺皮质增生症28例临床分析[J]. 四川医学, 2021, 42(3): 240-244.
|
[2]
|
刘西芳. 新生儿先天性肾上腺皮质增生症的诊疗分析(附43例报告) [D]: [硕士学位论文]. 合肥: 安徽医科大学, 2023.
|
[3]
|
Miller, W.L. and White, P.C. (2022) History of Adrenal Research: From Ancient Anatomy to Contemporary Molecular Biology. Endocrine Reviews, 44, 70-116. https://doi.org/10.1210/endrev/bnac019
|
[4]
|
罗飞宏. 先天性肾上腺皮质增生症诊断治疗进展[J]. 中华实用儿科临床杂志, 2015, 30(8): 564-569.
|
[5]
|
魏玉磊, 杨俊梅, 杨建丽, 解海珍. 17-OHP和ACTH联合检测在新生儿先天性肾上腺皮质增生症早期诊断中的应用研究[J]. 现代医药卫生, 2024, 40(1): 39-42.
|
[6]
|
张菊. 26例新生儿先天性肾上腺皮质增生症临床特征分析[J]. 河南医学研究, 2020, 29(33): 6168-6171.
|
[7]
|
毛千芊, 谷晓阳. 诸福棠与《诸福棠实用儿科学》[J]. 中国卫生人才, 2023(7): 56-58.
|
[8]
|
姜弟棣. 新生儿先天性肾上腺皮质增生症(附4例临床分析) [J]. 新生儿科杂志, 2000, 15(2): 74, 76.
|
[9]
|
陶红. 先天性肾上腺皮质增生症的临床与分子遗传学研究[D]: [博士学位论文]. 北京: 中国协和医科大学, 2003.
|
[10]
|
Pofi, R., Ji, X., Krone, N.P. and Tomlinson, J.W. (2023) Long‐term Health Consequences of Congenital Adrenal Hyperplasia. Clinical Endocrinology, 101, 318-331. https://doi.org/10.1111/cen.14967
|
[11]
|
Reddy, N.A., Sharma, S., Das, M., Kapoor, A. and Maskey, U. (2022) Devastating Salt‐Wasting Crisis in a Four‐Month‐Old Male Child with Congenital Adrenal Hyperplasia, Highlighting the Essence of Neonatal Screening. Clinical Case Reports, 10, e6010. https://doi.org/10.1002/ccr3.6010
|
[12]
|
Miller, W.L. and Auchus, R.J. (2011) The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders. Endocrine Reviews, 32, 81-151. https://doi.org/10.1210/er.2010-0013
|
[13]
|
Idkowiak, J., O'Riordan, S., Reisch, N., Malunowicz, E.M., Collins, F., Kerstens, M.N., et al. (2011) Pubertal Presentation in Seven Patients with Congenital Adrenal Hyperplasia Due to P450 Oxidoreductase Deficiency. The Journal of Clinical Endocrinology & Metabolism, 96, E453-E462. https://doi.org/10.1210/jc.2010-1607
|
[14]
|
White, P.C. and Speiser, P.W. (2000) Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency. Endocrine Reviews, 21, 245-291. https://doi.org/10.1210/edrv.21.3.0398
|
[15]
|
Hayashi, G.Y., Carvalho, D.F., de Miranda, M.C., Faure, C., Vallejos, C., Brito, V.N., et al. (2017) Neonatal 17‐Hydroxyprogesterone Levels Adjusted According to Age at Sample Collection and Birthweight Improve the Efficacy of Congenital Adrenal Hyperplasia Newborn Screening. Clinical Endocrinology, 86, 480-487. https://doi.org/10.1111/cen.13292
|
[16]
|
Rosenfield, R.L. (2021) Normal and Premature Adrenarche. Endocrine Reviews, 42, 783-814. https://doi.org/10.1210/endrev/bnab009
|
[17]
|
简永建. 新生儿先天性肾上腺皮质增生症筛查诊断实验方法学发展[J]. 中国儿童保健杂志, 2014, 22(10): 1065-1067.
|
[18]
|
Turcu, A.F., Nanba, A.T., Chomic, R., Upadhyay, S.K., Giordano, T.J., Shields, J.J., et al. (2016) Adrenal-Derived 11-Oxygenated 19-Carbon Steroids Are the Dominant Androgens in Classic 21-Hydroxylase Deficiency. European Journal of Endocrinology, 174, 601-609. https://doi.org/10.1530/eje-15-1181
|
[19]
|
Schröder, M.A.M., Turcu, A.F., O’Day, P., van Herwaarden, A.E., Span, P.N., Auchus, R.J., et al. (2021) Production of 11-Oxygenated Androgens by Testicular Adrenal Rest Tumors. The Journal of Clinical Endocrinology & Metabolism, 107, e272-e280. https://doi.org/10.1210/clinem/dgab598
|
[20]
|
Lao, Q., Burkardt, D.D., Kollender, S., Faucz, F.R. and Merke, D.P. (2023) Congenital Adrenal Hyperplasia Due to Two Rare CYP21A2 Variant Alleles, Including a Novel Attenuated CYP21A1P/CYP21A2 Chimera. Molecular Genetics & Genomic Medicine, 11, e2195. https://doi.org/10.1002/mgg3.2195
|
[21]
|
Xu, Z., Chen, W., Merke, D.P. and McDonnell, N.B. (2013) Comprehensive Mutation Analysis of the CYP21A2 Gene: An Efficient Multi-Step Approach to the Molecular Diagnosis of Congenital Adrenal Hyperplasia. The Journal of Molecular Diagnostics, 15, 745-753. https://doi.org/10.1016/j.jmoldx.2013.06.001
|
[22]
|
Merke, D.P. and Auchus, R.J. (2020) Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency. New England Journal of Medicine, 383, 1248-1261. https://doi.org/10.1056/nejmra1909786
|
[23]
|
徐钰琪, 林彩娟, 耿国兴, 李威, 阳奇, 罗静思. 391714例新生儿先天性肾上腺皮质增生症筛查与基因检测[J]. 实用医学杂志, 2022, 38(14): 1825-1829.
|
[24]
|
中华医学会儿科分会罕见病学组, 中国医师协会医学遗传医师分会, 中国妇幼保健协会出生缺陷防治与分子遗传分会, 上海市医学会分子诊断专科分会, 孙昱, 邬玲仟, 叶蕾, 邱文娟, 余永国. 21羟化酶缺陷导致的先天性肾上腺皮质增生症的实验室诊断共识[J]. 中华医学遗传学杂志, 2023, 40(7): 769-780.
|
[25]
|
蔡芸莹, 苏恒. 先天性肾上腺皮质增生症与肾上腺皮质肿瘤的分子遗传学研究进展[J]. 中华临床医师杂志(电子版), 2013, 7(22): 10298-10300.
|
[26]
|
Clayton, P.E., Miller, W.L., Oberfield, S.E., Ritzén, E.M., Sippell, W.G., Speiser, P.W. and ESPE/LWPES CAH Working Group (2002) Consensus Statement on 21-Hydroxylase Deficiency from the European Society for Paediatric Endocrinology and the Lawson Wilkins Pediatric Endocrine Society. Hormone Research, 58, 188-195.
|
[27]
|
Hannah-Shmouni, F., Morissette, R., Sinaii, N., Elman, M., Prezant, T.R., Chen, W., et al. (2017) Revisiting the Prevalence of Nonclassic Congenital Adrenal Hyperplasia in US Ashkenazi Jews and Caucasians. Genetics in Medicine, 19, 1276-1279. https://doi.org/10.1038/gim.2017.46
|
[28]
|
Gidlöf, S., Falhammar, H., Thilén, A., von Döbeln, U., Ritzén, M., Wedell, A., et al. (2013) One Hundred Years of Congenital Adrenal Hyperplasia in Sweden: A Retrospective, Population-Based Cohort Study. The Lancet Diabetes & Endocrinology, 1, 35-42. https://doi.org/10.1016/s2213-8587(13)70007-x
|
[29]
|
Tseretopoulou, X., Bryce, J., Chen, M., McMillan, M., Lucas‐Herald, A.K., Ali, S.R., et al. (2023) The I‐CAH Registry: A Platform for International Collaboration for Improving Knowledge and Clinical Care in Congenital Adrenal Hyperplasia. Clinical Endocrinology, 101, 397-404. https://doi.org/10.1111/cen.14961
|
[30]
|
Held, P.K., Shapira, S.K., Hinton, C.F., Jones, E., Hannon, W.H. and Ojodu, J. (2015) Congenital Adrenal Hyperplasia Cases Identified by Newborn Screening in One-and Two-Screen States. Molecular Genetics and Metabolism, 116, 133-138. https://doi.org/10.1016/j.ymgme.2015.08.004
|